Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03281928
Other study ID # IRB17-0992
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date October 1, 2017
Est. completion date December 20, 2022

Study information

Verified date October 2021
Source University of Chicago
Contact Elaine Worcester
Phone 773-702-3630
Email eworcest@uchicago.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study intends to characterize the affect of sodium and potassium citrate in the diet on renal function.


Recruitment information / eligibility

Status Recruiting
Enrollment 52
Est. completion date December 20, 2022
Est. primary completion date December 20, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria: - age 18 - 70, approximately equal numbers of men and women - studied by endoscopy with complete papillary mapping and grading - stone formers Exclusion Criteria: - Patients with primary renal diseases or renal impairment (eGFR < 90), or medical conditions such as diabetes, or systemic diseases or medications that alter calcium metabolism - Patients with known bladder voiding problems

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Sodium and Potassium Citrate
Sodium and potassium citrate levels will be altered in diet and renal mineral handling will be measured as compared to placebo.
Placebo
Sodium without Potassium Citrate

Locations

Country Name City State
United States University of Chicago Medical Center Chicago Illinois

Sponsors (1)

Lead Sponsor Collaborator
University of Chicago

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Urine Calcium levels Amount of calcium in the urine will be measured 10 days
See also
  Status Clinical Trial Phase
Recruiting NCT04495699 - Asymptomatic Renal Calculi in Recurrent Urinary Tract Infections
Recruiting NCT04559321 - Holmium Vs Trilogy Kidney Stones GUY's 1-2 Phase 3
Completed NCT04332861 - Evaluation of Infection in Obstructing Urolithiasis
Withdrawn NCT06138327 - A Study of BMN 255 in Participants With Non-Alcoholic Fatty Liver Disease And Hyperoxaluria Phase 1
Not yet recruiting NCT05022537 - Clinical Outcomes of Percutaneous Nephrolithotomy Following Retrograde Percutaneous Nephrostomy Access Using Novel Device in Comparison to Antegrade Access N/A
Completed NCT03872843 - Opioid Free Management After Ureteroscopy Phase 4
Recruiting NCT06412822 - Neutrophil Extracellular Traps (NET's) in Prevalent Kidney Stone
Active, not recruiting NCT06437379 - Infection Control Measures for Patients Undergoing Percutaneous Nephrolithotomy N/A
Recruiting NCT04997668 - Clinical Outcomes and Healthcare Economics of SOLTIVE Compared to Ho:YAG Laser in Urolithiasis N/A
Active, not recruiting NCT04333745 - Influence of Obesity on Oxalate Metabolism and Handling in Calcium Oxalate Stone Formers N/A
Recruiting NCT05701098 - SOUND Pivotal Trial - (Sonomotion stOne comminUtion resoNance ultrasounD) N/A
Recruiting NCT04389853 - Mini-PNCL vs fURS in Management of Nephrolithiasis N/A
Recruiting NCT05334979 - Oxalate and Citrate N/A
Recruiting NCT05591716 - Evaluation of the Efficacy and Safety of Unimodal Bilateral Flexible Ureteroscopy. N/A
Recruiting NCT06209931 - RIRS With Tip Flexible Pressure-controlling Ureteral Access Sheath Versus Mini PCNLfor Kidney Stones
Withdrawn NCT04545528 - The Impact of Nutritional Service in the Stone Clinic on the Patient Urine Collection Results
Completed NCT05714423 - Outcomes in Lower Pole Kidney Stone Management Using Mini-PCNL Compared With Retrograde Intra Renal Surgery N/A
Recruiting NCT04835922 - Comparison of Efficacy of Intercostal Nerve Block vs Peritract Infiltration With 0.25% Bupivacaine in PCNL N/A
Recruiting NCT03257306 - Magnetic Ureteral Stent Symptoms - a Comparison to Standard Ureteral Stent as Perceived By the Patient (MAGUSS) N/A
Not yet recruiting NCT05504512 - Percutaneous Nephroscopic Treatment of Parapelvic Cysts